A role for intravenous immunoglobulin in the treatment of Acquired Von Willebrand Syndrome associated with IgM gammopathy

Haemophilia. 2018 Jan;24(1):e22-e25. doi: 10.1111/hae.13374. Epub 2017 Nov 22.

Authors

M Lavin^{1

2}, K Ryan¹, B White¹, M Byrne¹, N M O'Connell¹, J S O'Donnell^{1

2}

Affiliations

¹ National Coagulation Centre, St. James's Hospital, Dublin, Ireland.
² Department of Molecular and Cellular Therapeutics, Irish Centre for Vascular Biology, Royal College of Surgeons in Ireland, Ireland.

PMID: 29168278
DOI: 10.1111/hae.13374

No abstract available

Publication types

Letter

MeSH terms

Humans
Immunoglobulin M / metabolism*
Immunoglobulins, Intravenous / therapeutic use*
Middle Aged
Paraproteinemias / complications*
von Willebrand Diseases / blood
von Willebrand Diseases / complications*
von Willebrand Diseases / drug therapy*
von Willebrand Factor / metabolism

Substances

Immunoglobulin M
Immunoglobulins, Intravenous
von Willebrand Factor